ES2174446T3 - Anticoagulacion de productos de sangre, plasma sanguineo o de liquido senovial. - Google Patents

Anticoagulacion de productos de sangre, plasma sanguineo o de liquido senovial.

Info

Publication number
ES2174446T3
ES2174446T3 ES98928727T ES98928727T ES2174446T3 ES 2174446 T3 ES2174446 T3 ES 2174446T3 ES 98928727 T ES98928727 T ES 98928727T ES 98928727 T ES98928727 T ES 98928727T ES 2174446 T3 ES2174446 T3 ES 2174446T3
Authority
ES
Spain
Prior art keywords
blood
citrate
iso
products
blood plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98928727T
Other languages
English (en)
Inventor
Mats Ranby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Hemostasis Institute MGR AB
Original Assignee
Global Hemostasis Institute MGR AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Hemostasis Institute MGR AB filed Critical Global Hemostasis Institute MGR AB
Application granted granted Critical
Publication of ES2174446T3 publication Critical patent/ES2174446T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dentistry (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)

Abstract

Procedimiento de anticoagulación de un producto de sangre, plasma sanguíneo o líquido sinovial que comprende el paso de añadir al producto una cantidad efectiva de isocitrato de 15-50 mmoles por litro de producto de sangre anticoagulada o 25-70 mmoles por litro de producto de plasma sanguíneo o líquido sinovial anticoagulado.
ES98928727T 1997-06-05 1998-05-29 Anticoagulacion de productos de sangre, plasma sanguineo o de liquido senovial. Expired - Lifetime ES2174446T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5292997P 1997-06-05 1997-06-05

Publications (1)

Publication Number Publication Date
ES2174446T3 true ES2174446T3 (es) 2002-11-01

Family

ID=21980831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98928727T Expired - Lifetime ES2174446T3 (es) 1997-06-05 1998-05-29 Anticoagulacion de productos de sangre, plasma sanguineo o de liquido senovial.

Country Status (10)

Country Link
US (1) US6368785B1 (es)
EP (1) EP0986394B1 (es)
JP (1) JP2001527530A (es)
CN (1) CN1104902C (es)
AT (1) ATE214282T1 (es)
AU (1) AU8045498A (es)
CA (1) CA2292595A1 (es)
DE (1) DE69804216T2 (es)
ES (1) ES2174446T3 (es)
WO (1) WO1998055129A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206648A1 (de) * 2002-02-15 2003-09-11 November Ag Molekulare Medizin Wirkstoff zur Herstellung eines Stoffs zur Beeinflussung der Koagulationsbereitschaft des Bluts
US8506933B2 (en) * 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
WO2010112538A1 (en) 2009-03-31 2010-10-07 Gambro Lundia Ab A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
AU2010262902B2 (en) * 2009-06-17 2013-05-02 Fresenius Medical Care Holdings, Inc. Methods of regional citrate anticoagulation dialysis
CA2781664A1 (en) * 2009-11-27 2011-06-03 Msdx, Inc. Methods of detecting or monitoring activity of an inflammatory or neurodegenerative condition
US8673309B2 (en) 2011-02-11 2014-03-18 Msdx, Inc. Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828976A (en) * 1983-12-29 1989-05-09 Thomas Jefferson University Glucose free media for storing blood platelets
DE3615558A1 (de) 1986-05-09 1987-11-12 Behringwerke Ag Verfahren zur herstellung eines faktor v-konzentrats
US5175087A (en) * 1987-07-06 1992-12-29 Biopool International, Inc. Method of performing tissue plasminogen activator assay
GB8808004D0 (en) 1988-04-06 1988-05-05 Erdinc A Baby seat

Also Published As

Publication number Publication date
DE69804216T2 (de) 2002-11-07
WO1998055129A1 (en) 1998-12-10
JP2001527530A (ja) 2001-12-25
ATE214282T1 (de) 2002-03-15
EP0986394B1 (en) 2002-03-13
CA2292595A1 (en) 1998-12-10
DE69804216D1 (de) 2002-04-18
EP0986394A1 (en) 2000-03-22
US6368785B1 (en) 2002-04-09
CN1265036A (zh) 2000-08-30
AU8045498A (en) 1998-12-21
CN1104902C (zh) 2003-04-09

Similar Documents

Publication Publication Date Title
Aruoma et al. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy
Levine et al. Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet reactions.
AU6933900A (en) Method, reagent and test cartridge for determining clotting time
Gagnon et al. Characterization of a mouse model of chronic uremia
ATE237926T1 (de) Verfahren und vorrichtung zum konservieren von biologischen materialien
Carr et al. The effect of dextran 70 on the structure of plasma-derived fibrin gels
ATE360363T1 (de) Verfahren und anordnung von beuteln zur konzentrierung weisser zellen
Hepinstall et al. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen
JP7027589B2 (ja) 採血管、試薬及びそれらを利用した血液性状分析方法
ES2174446T3 (es) Anticoagulacion de productos de sangre, plasma sanguineo o de liquido senovial.
US11291201B2 (en) Solutions for increasing the stability and shelf life of an organ and tissue preservation solution
Landt et al. Interference in ionized calcium measurements by heparin salts
ATE267518T1 (de) Zusammensetzungen und verfahren zum konservieren von blutplättchen
BE47T1 (fr) Procede et reactif pour la determination de la teneur en hemoglobine du sang
CA2242693C (en) Additive formulation and method of use thereof
Ghiselli et al. New approaches for measuring plasma or serum antioxidant capacity: a methodological note
Shen et al. Differential activities of heparins in human plasma and in sheep plasma. Effects of heparin molecular sizes and sources
Marx et al. Zinc alters fibrin ultrastructure
Åkerblom et al. Freezing technique and quality of fresh-frozen plasma
ES2055190T3 (es) Amidas de acido carboxilico que forman con los iones magnesio complejos lipofilos, procedimiento para la preparacion de los complejos de magnesio lipofilos y partes selectivas de iones.
Ts' ao et al. Effect of dextran on platelet activation by polymerizing fibrin.
Zbinden et al. Assessment of damage to human platelets after aggregation and other injuries by microscopic observation and estimation of serotonin uptake
Kottke-Marchant et al. The effect of heparin vs. citrate on the interaction of platelets with vascular graft materials
ES2110998T3 (es) Procedimiento para la determinacion de las trombopenias.
Murphy et al. Endogenous anticoagulation during extracorporeal perfusion: generation of a heparinlike inhibitor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 986394

Country of ref document: ES